Clinical Trial Update: GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 clinical trial evaluating GSK1278863 for its effects on eccentric exercise-induced muscle damage related to tendo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tendon Injuries

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tendon Injuries | Phase 1 | Status: COMPLETED